(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a ...